Results 11 to 20 of about 7,937 (220)

Diagnosis of Transthyretin Amyloid Cardiomyopathy [PDF]

Cardiology and Therapy, 2020
Transthyretin amyloid cardiomyopathy (ATTR-CM) continues to be an easily overlooked, life-threatening, yet treatable cause of heart failure. Furthermore, its elusive diagnosis leads to late or misdiagnosis.
Adam S. Hafeez, Anthony A. Bavry
doaj   +3 more sources

Hereditary transthyretin amyloid cardiomyopathy

Singapore Medical Journal, 2023
10.4103/singaporemedj.SMJ-2021-300 ; Singapore medical journal ; 64 ; 1 ; 74 ...
Yiliang Zheng, Ching-Hui Sia, Raymond Ching Chew Wong, Roger Sik Yin Foo, Weiqin Lin, Devinder Singh, Yoke Ching Lim   +6 more
doaj   +3 more sources

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy

Arquivos Brasileiros de Cardiologia, 2016
Background: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellular spaces. The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met.
Alexandre Marins Rocha, Suzane Garcia Ferreira, Marcelo Souto Nacif, Mario Luiz Ribeiro, Marcos Raimundo Gomes de Freitas, Cláudio Tinoco Mesquita   +5 more
doaj   +5 more sources

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy

ESC Heart Failure
Aims Recognition of transthyretin amyloid cardiomyopathy is increasing due to advances in cardiac imaging and diagnostic strategies, but questions remain regarding disease frequency and characteristics.
Pablo Garcia‐Pavia, Thibaud Damy, Nicolas Piriou, Roberto Barriales‐Villa, Francesco Cappelli, Catherine Bahus, Carmen Munteanu, Denis Keohane, Pablo Mallaina, Perry Elliott, the TTRACK investigators   +10 more
doaj   +3 more sources

Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non-Pharmacological Therapy. [PDF]

J Arrhythm
Transthyretin amyloid cardiomyopathy (ATTR‐CM) frequently coexists with atrial fibrillation, atrial flutter, and atrial tachycardia as well as occasionally ventricular arrhythmias and often conduction abnormalities, necessitating management for arrhythmias.
Kanazawa H, Hoshiyama T, Kaneko S, Kawahara Y, Tsuruta Y, Tsurusaki Y, Matsunaga K, Tamanoi S, Kuyama N, Usuku H, Yamamoto E, Izumiya Y, Tsujita K.   +12 more
europepmc   +2 more sources

Wild Type Transthyretin Amyloid Cardiomyopathy Hidden Under Ablation-Refractory Atrial Arrhythmias and the Potential Contribution of Tafamidis in Rhythm Control. [PDF]

J Arrhythm
An octogenarian man with a history of multiple catheter ablation failures for atrial fibrillation and tachycardia was diagnosed with transthyretin amyloid cardiomyopathy. After 1 year of tafamidis therapy, the patient experienced spontaneous restoration of sinus rhythm, and follow‐up image of 99mTc‐pyrophosphate scintigraphy revealed a marked decrease ...
Horie T, Nagata Y, Nozato T, Miyazaki S, Ashikaga T.   +4 more
europepmc   +2 more sources

Transthyretin Amyloid Cardiomyopathy: The Role and Reach of SGLT2 Inhibitors. [PDF]

JACC Adv
Karakasis P.
europepmc   +2 more sources

Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart

JACC: Case Reports, 2023
Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is more prevalent than appreciated in the elderly. We present the case of an 88-year-old woman who underwent heart transplantation for ischemic cardiomyopathy and then presented 21 years later ...
Lily K. Stern, MD, Pamela A. Ivey, MD, Corey J. Lum, DO, Shayaan Zaidi, Daniel Luthringer, MD, Angela Velleca, BSN, CCTC, Jon A. Kobashigawa, MD, Jignesh K. Patel, MD, PhD, Michelle M. Kittleson, MD, PhD   +8 more
doaj   +1 more source

Systemic embolism in amyloid transthyretin cardiomyopathy

European Journal of Heart Failure, 2022
AimsAlthough systemic embolism is a potential complication in transthyretin amyloid cardiomyopathy (ATTR‐CM), data about its incidence and prevalence are scarce. We studied the incidence, prevalence and factors associated with embolic events in ATTR‐CM.
Vilches, Silvia, Fontana, Marianna, Gonzalez‐Lopez, Esther, Mitrani, Lindsey, Saturi, Giulia, Renju, Mary, Griffin, Jan M., Caponetti, Angelo, Gnanasampanthan, Sahana, De los Santos, Jeffeny, Gagliardi, Christian, Rivas, Adrian, Dominguez, Fernando, Longhi, Simone, Rapezzi, Claudio, Maurer, Mathew S., Gillmore, Julian, Garcia‐Pavia, Pablo   +17 more
openaire   +9 more sources

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review

Biomedicines, 2023
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly diagnosed condition. Although wild-type transthyretin amyloidosis (ATTRwt) is the most common ATTR-CM, hereditary transthyretin amyloidosis (ATTRv) may also occur.
Ana-Maria Merino-Merino, Jorge Labrador-Gomez, Ester Sanchez-Corral, Pedro-David Delgado-Lopez, Jose-Angel Perez-Rivera   +4 more
doaj   +1 more source